Relmada Therapeutics (RLMD) Earnings
|
Expand Research on RLMD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/24/26  |
Q425 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/25 | Q325 | -$0.30 | -$0.45 | +$0.15 | N/A | N/A | N/A |  | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/25 | Q225 | -$0.30 | -$0.40 | +$0.10 | N/A | N/A | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.58 | -$0.37 | -$0.21 | N/A | N/A | N/A | | | Details | |
| 5/9/25 |
Q125 | N/A | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/25 |
Q125 | N/A | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A |
